The estimated Net Worth of Leslie E Donato is at least $2.02 Millón dollars as of 1 July 2023. Ms. Donato owns over 1,432 units of Amerisource Bergen stock worth over $1,364,608 and over the last 5 years she sold ABC stock worth over $658,786. In addition, she makes $0 as Executive Vice President and Chief Strategy Officer at Amerisource Bergen.
Leslie has made over 7 trades of the Amerisource Bergen stock since 2021, according to the Form 4 filled with the SEC. Most recently she exercised 1,432 units of ABC stock worth $257,731 on 1 July 2023.
The largest trade she's ever made was exercising 4,349 units of Amerisource Bergen stock on 9 November 2022 worth over $782,733. On average, Leslie trades about 910 units every 35 days since 2019. As of 1 July 2023 she still owns at least 7,582 units of Amerisource Bergen stock.
You can see the complete history of Ms. Donato stock trades at the bottom of the page.
Leslie E. Donato serves as Executive Vice President and Chief Strategy Officer of the Company. She brings nearly 30 years of long-range strategy and healthcare industry experience. Most recently at Bayer Pharmaceuticals, Ms. Donato developed an integrated global pharmaceutical strategy and a U.S. growth strategy, oversaw the U.S. business for both hematology and neurology, and led the global strategic marketing team for neurology. Prior to Bayer, Ms. Donato was a Partner at McKinsey & Company specializing in healthcare. Throughout her tenure, Ms. Donato has developed extensive expertise in understanding global business development, accelerating strategic growth, driving company transformation and re-design and empowering employee engagement.
Leslie Donato is 50, she's been the Executive Vice President and Chief Strategy Officer of Amerisource Bergen since 2019. There are 23 older and 1 younger executives at Amerisource Bergen. The oldest executive at Amerisource Bergen Corp. is Jane Henney, 72, who is the Lead Independent Director.
Leslie's mailing address filed with the SEC is , 1 WEST FIRST AVENUE, CONSHOHOCKEN, PA, 19428.
Over the last 21 years, insiders at Amerisource Bergen have traded over $4,389,593,610 worth of Amerisource Bergen stock and bought 18,610 units worth $1,659,872 . The most active insiders traders include Boots Alliance, Inc.Walgree..., Lon R Greenberg y Steven H Collis. On average, Amerisource Bergen executives and independent directors trade stock every 14 days with the average trade being worth of $13,111,903. The most recent stock trade was executed by Steven H Collis on 8 August 2023, trading 10,499 units of ABC stock currently worth $813,987.
amerisourcebergen is driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain and enhance patient care. as the leader in global sourcing and distribution, we source and distribute brand, generic, specialty, otc pharmaceuticals and other healthcare products. we increase the effectiveness and efficiency of your supply chain by ensuring products are delivered securely, consistently and cost-effectively, improving product access for pharmacies, providers and patients. our pharmacy solutions result in greater operational efficiency, cost control, growth opportunities and patient safety. our provider solutions drive operational efficiency, financial performance and improve quality of care. our manufacturer solutions maximize success at every stage of the product lifecycle. amerisourcebergen. where knowledge, reach and partnership shape healthcare delivery.
Amerisource Bergen executives and other stock owners filed with the SEC include: